ResMed CEO Covers Taxes with $2.0M Stock Disposition
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
ResMed CEO Covers Taxes with $2.0M Stock Disposition
Company: RESMED INC (RMD) Form: 4 | Filed: 2025-11-13 Significance: Low
Insider: Farrell Michael J. Title: Chairman and CEO | Relationship: Director, Officer
Transaction: • Type: Tax Withholding Sale • Shares: 7,896.567 • Price: $250.10 • Value: $1,974,931 • Owned After: 462,059 (Direct & Indirect)
Key Insight: This is an automatic disposition to cover tax obligations from vesting RSUs, not a discretionary sale. It carries minimal informational value regarding the executive's outlook.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: RESMED INC (RMD)
Executive Summary
- Trading Significance: Low
- Key Takeaway: The Chairman and CEO, Michael J. Farrell, disposed of shares worth approximately $2.0 million in a non-discretionary transaction to cover tax liabilities associated with vesting Restricted Stock Units (RSUs).
- Market Impact: Neutral. This type of transaction is routine and does not signal a change in insider sentiment.
Company Information
| Field | Value |
|---|---|
| Company | RESMED INC |
| Ticker Symbol | RMD |
| CIK | 0000943819 |
| Industry | Surgical & Medical Instruments & Apparatus |
Insider Information
| Field | Value |
|---|---|
| Name | Farrell Michael J. |
| CIK | 0001485164 |
| Title/Position | Chairman and CEO |
| Relationship | Director, Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-11-11 |
| Transaction Code | F - Payment of tax liability by withholding securities |
| Security Type | ResMed Common Stock |
| Shares Involved | 7,896.567 |
| Price Per Share | $250.10 |
| Total Value | $1,974,931.41 |
| Shares Owned After | 462,059 (459,969 Direct, 2,090 Indirect) |
| Ownership Type | Direct |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $1,974,931.41 |
| % of Market Cap | 0.0054% |
| Shares Transacted | 7,896.567 |
| % of Shares Outstanding | 0.0054% |
| Post-Transaction Ownership | 462,059 shares (0.316% of outstanding) |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: The $2.0 million transaction is negligible compared to ResMed's market capitalization of $36.51 billion, representing just 0.0054% of its value.
- Ownership Concentration: The insider's post-transaction holding of 0.316% of outstanding shares remains a substantial position, indicating continued alignment with shareholder interests.
- Transaction Significance: The transaction is classified as low significance. The value and share count are well below the thresholds for moderate or high significance. The nature of the transaction (tax withholding) further reduces its importance as a market signal.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The filing explicitly states the disposition was to cover tax withholding obligations on vesting RSUs (Transaction Code 'F'). This is a common, automated, and non-discretionary event that does not reflect an insider's voluntary decision to sell shares based on their outlook for the company.
Volume & Sentiment
- Expected Volume Impact: Minimal. The transaction is too small relative to the company's size and average trading volume to have a noticeable impact.
- Sentiment Indicator: Neutral. The market typically disregards 'sell-to-cover' transactions as they are not indicative of an insider's confidence.
Additional Context
Transaction Notes
- Special Circumstances: The footnotes confirm three separate dispositions on the same day, all for tax withholding on RSUs granted in 2022, 2023, and 2024. This is a planned and mechanical process tied to the executive's compensation structure.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
